Effectiveness of a Novel Device for Cervical Training in Cervicogenic Headache.

January 25, 2023 updated by: Pilar Pardos Aguilella, Universitat Internacional de Catalunya

Effectiveness of a Novel Device for Cervical Training in Cervicogenic Headache. Randomized Clinical Trial.

The purpose of this study is to evaluate the clinical results in cervical spine range of motion, endurance deep cervical muscles, headache impact and physical activity enjoyment by a training protocol with the new device for cervical treatment (CDAT) versus conventional training protocol (CT) in subjects with cervicogenic headache.

Study Overview

Detailed Description

The cervical spine is the most mobile region of the spine and must be strong enough to support the weight of the skull. Strength deficits of the deep cervical muscles are related to different clinical conditions, such as cervicogenic headache. Cervicogenic headache is a secondary headache defined as a unilateral headache associated with neck pain, related to a decreased cervical range of motion and strength deficits of the deep cervical muscles.

Training protocols can help to improve pain, function, posture and cross-sectional area. However, there are no training protocols in subjects with cervicogenic headache including deep neck extensor and flexor muscles. The cervical device treatment (CDAT) allows us to train the cervical flexor and extensor muscle in a simple and comfortable way.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zaragoza, Spain, 50018
        • Élite Fisioterapia, María Montessori 2.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Deep flexor strength deficit in craniocervical flexion test.
  • Deep extensor strength deficit in neck extensor muscle endurance.
  • A positive result in the flexion-rotation test
  • ≥ 50 score in Headache Impact Test (HIT-6).
  • Diagnosis of cervicogenic headache according to Sjaastad et al. Subjects will have to fulfill both parts I and III of the major criteria for diagnosis (pain aggravated by neck movement, sustained position or external pressure, restricted cervical range of motion, and unilateral pain starting in the neck and radiating to the frontotemporal region)

Exclusion Criteria:

  • Have received head/cervical treatment during the last six month, presented any red flag, neurological or cognitive impairment (inability to understand the questionnaires or examination).
  • Have received cervical manual therapy treatment during the last six month
  • A history of head/cervical trauma or surgery during the last year.
  • The use of pacemakers (the magnets in the CROM device could alter their signal
  • Inability to perform the flexion-rotation test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Training protocol with the cervical device for treatment (CDAT).
Endurance training program of deep cervical flexors and deep cervical extensors with the cervical device for treatment.
Endurance training program of deep cervical flexors and deep cervical extensors with the cervical device for treatment.
Active Comparator: Conventional training protocol
Endurance training program of deep cervical flexors and deep cervical extensors with the conventional protocol.
Endurance training program of deep cervical flexors and deep cervical extensors with the conventional protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Flexion Rotation Test (FRT)
Time Frame: Change between baseline and post intervention (6 weeks) and after 10 weeks.

Mean change from baseline in Flexion-rotation test after 6 weeks and 10 weeks.

The examiners assess the cervical ROM using CROM (Cervical Range-of-Motion Instrument). Flexion rotation test will be evaluated. Flexion rotation test is used to see the amount of movement of the upper cervical spine and is the test most used in the literature. It is positive when there is a decrease of 10 degrees or more in the cervical rotation with maximum flexion, in a sense with respect to the contralateral or presents hypomobility of segment C1 with a mobility less than 32.

Change between baseline and post intervention (6 weeks) and after 10 weeks.
Change in Headache Impact Test (HIT-6) (Headache Disfunction)
Time Frame: Change between baseline and post intervention (6 weeks) and after 10 weeks.

Mean change from baseline in Headache Impact Test (HIT-6) after 6 weeks and 10 weeks.

The examiners assess the impact of headache on patients' lives using the HIT-6. Very severe impact: 60 or more. Major impact: 56-59 score Some impact: 50-55 score Little or no impact: 49 or less.

Change between baseline and post intervention (6 weeks) and after 10 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Craniocervical flexion test
Time Frame: Baseline and 6 weeks, 10 weeks.
The examiners assess the strength of deep cervical flexors with craniocervical flexion test.
Baseline and 6 weeks, 10 weeks.
Cervical Spine Range of Motion (ROM).
Time Frame: Baseline and 6 weeks, 10 weeks.

Mean change from baseline in Cervical Spine Range of Movement (ROM) after 6 weeks and 10 weeks.

The examiners assess the cervical ROM using CROM (Cervical Range-of-Motion Instrument). Cervical flexion, extension, right/left sidebending, right/left rotation will be evaluated.

The examiners assess the cervical ROM using CROM (Cervical Range-of-Motion Instrument). Upper cervical flexion, upper cervical extension will be evaluated.[Time Frame: Baseline and 6 weeks, 10 weeks]

Baseline and 6 weeks, 10 weeks.
Deep neck flexor endurance Test.
Time Frame: Baseline and 6 weeks, 10 weeks.
Chin Tuck Neck Flexion Test is an assessment technique intended to determine the endurance of the deep cervical flexors.
Baseline and 6 weeks, 10 weeks.
Physical activity enjoyment Scale (PACES)
Time Frame: 6 weeks

The examiners assess participant satisfaction with cervical deep muscle training.

This scale measures enjoyment during physical activity through 16 items, which are preceded by the phrase "When I am active…" This instrument measures enjoyment and bipolar enjoyment, through statements such as "I enjoy it", "I'm bored", "It's very exciting", and "I don't like it". The answers will be collected on a Likert scale from 1 (totally disagree) to 5 (totally agree).

6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pilar Pardos-Aguilella, UicCatalunya

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2022

Primary Completion (Actual)

October 15, 2022

Study Completion (Actual)

November 15, 2022

Study Registration Dates

First Submitted

July 25, 2022

First Submitted That Met QC Criteria

July 27, 2022

First Posted (Actual)

July 29, 2022

Study Record Updates

Last Update Posted (Actual)

January 27, 2023

Last Update Submitted That Met QC Criteria

January 25, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervicogenic Headache

Clinical Trials on Training protocol with the cervical device for treatment (CDAT).

Subscribe